Loss of menin expression as determined through IHC has been reported in MEN1-related tumors in retroperitoneal NETs (24), multifocal pancreatic NETs (25), adrenocortical carcinomas (26), and thymic NETs (27). This evidence concerns the gene MEN1 and pancreatic neuroendocrine tumor.